BocaGreenMD: Prena1 Generic Prescription Prenatal Vitamins

Published Online: Tuesday, July 23, 2013

Not All Generic Prescription Prenatals Are Created Equal

BocaGreenMD is a pharmaceutical company that specializes in providing generic pharmaceutical and nutritional health care products focused on improving the health, wellness, and quality of life for women of all ages.

BocaGreenMD’s Prena1 line of generic prescription prenatal vitamins contains a unique, proprietary blend of 1 mg of folate as 600 mcg of Quatrefolic®, the fourth-generation folate that bypasses MTHFR polymorphisms, and 400 mcg of folic acid:
  • Prena1 Plus, a comprehensive, daily dietary supplement, provides 16 vitamins and minerals per multivitamin tablet, plus 300 mg of DHA per softgel.
  • Prena1, a convenient, single daily softgel, contains essential vitamins, minerals, and 200 mg of DHA.
  • Prena1 Chew, a unique, vanilla-flavored, easy-to-chew tablet, dissolves quickly, making it ideal for women planning a pregnancy or who are pregnant and have difficulty swallowing tablets or capsules. Prena1 Chew includes vitamins B6 and B12 to help relieve nausea and morning sickness.

All Prena1 prenatal vitamins are gluten, lactose, sugar, and fish free.

Prena1, Prena1 Plus, and Prena1 Chew are available by prescription only at chain, independent, and mail order pharmacies throughout the United States. $15 rebate coupons for all 3 products are offered to patients at and at many pharmacies nationwide.

BocaGreenMD is a subsidiary of TherapeuticsMD, a specialty pharmaceutical company based in Boca Raton, Florida, that is focused on the sales, marketing, and development of branded and generic pharmaceutical and OTC products primarily for the women’s health care market.

For more information on BocaGreenMD and Prena1 prenatal vitamins, visit

For more information on TherapeuticsMD and its subsidiaries, visit

Latest Articles
This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.
Chronic kidney disease incidence has grown faster than many of its common comorbidities such as diabetes and hypertension, and medications may be an underappreciated driver of this growth.
President Barack Obama’s fiscal year 2017 budget proposal calls for an additional $1.1 billion to combat the nation’s spiraling opioid epidemic.
Baxter International is voluntarily recalling intravenous solution due to leaking containers and the potential for particulate matter.
Latest Issues